Latest FluoGuide News & Updates

See the latest news and media coverage for FluoGuide. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
FluoGuide

Biotechnology company developing fluorescent cancer surgery drugs

fluoguide.com
Headquarters
Copenhagen, Denmark
Founded year
2018
Company type
Private company
Number of employees
2–15
Industry
Pharmaceuticals

Last updated

Latest news about FluoGuide

In short: FluoGuide advanced its lead candidate FG001, securing FDA Fast Track Designation and reporting positive Phase 2 results for oral cancer.

Company announcements

FluoGuide

FluoGuide presents positive interim FG001 study results

Dr. Jane Skjøth-Rasmussen shared data at Brain Tumor Symposium 2026 in Copenhagen, highlighting FG001's potential to improve tumor delineation in meningioma and low-grade glioma surgery.

Unlock all announcements with a

Media coverage

Yahoo Finance

Update on 2026 Outlook and Company Progress

COPENHAGEN, DK / ACCESS Newswire / July 1, 2026 / FluoGuide A/S ("FluoGuide" or the "Company")(STO:FLUO) , a clinical-stage biotech company focused on precision cancer...

MarketWatch

FluoGuide A/S

Visit a quote page and your recently viewed tickers will be displayed here.

Morningstar

FluoGuide AS Ordinary Shares

Review the current valuation for FluoGuide AS Ordinary Shares (FLUO:XSTO) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company...

Unlock all articles with a

Never miss news about FluoGuide

Track FluoGuide and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.